Names and pronunciation
(zoh′leh-drah′nick ass′id) Aclasta , Reclast, Zometa
Source page 1399
Loading InternPractice…
Individual generic drug information
Extracted information for zoledronic acid only.
(zoh′leh-drah′nick ass′id) Aclasta , Reclast, Zometa
Source page 1399
Func. class.: Bone-resorption inhibitor
Source page 1399
Chem. class.: Bisphosphonate
Source page 1399
USES: Moderate to severe hyper calcemia associated with malignancy; multiple myeloma; bone metastases from solid tumors (used with antineoplastics); active Paget’s disease; osteoporosis, glucocorticoid-induced osteoporosis, osteoporosis prophylaxis in postmen opausal women
Source page 1399
Extracted information for zoledronic acid only.
DOSAGE AND ROUTES Hypercalcemia of malignancy • Adult: IV INFUSION 4 mg, given as single infusion over ≥15 min; may re-treat with 4 mg if serum calcium does not return to normal within 1 wk Multiple myeloma/metastatic bone lesions • Adult: IV INFUSION 4 mg, give over 15 min q3-4wk Osteoporosis • Adult: IV INFUSION 5 mg over ≥15 min q12mo Active Paget’s disease (Reclast) • Adult: IV INFUSION 5 mg over ≥15 min with 1500 mg elemental calcium in divided doses and 800 IU of vitamin D Osteoporosis prophylaxis (Reclast), postmenopausal women • Adult: IV INFUSION 5 mg every other year Osteoporosis prophylaxis (Reclast) when taking systemic glucocorticoids • Adult: IV 5 mg every year Renal dose • Adult: IV INFUSION CCr 50-60 mL/min, 3.5 mg; CCr 40-49 mL/min, 3.3 mg; CCr 30- 39 mL/min, 3 mg; CCr <30 mL/min, do not use Osteopenia prevention in androgen deprivation treatment (prostate cancer) (unlabeled) • Adult: IV 4 mg q6-12mo or 5 mg q12mo
Source page 1399
Available forms: sol for inj 4 mg/5 mL; (Aclasta , Reclast) inj 5 mg/100 mL
Source page 1399
Filter the extracted dose blocks for this individual drug.
Hypercalcemia of malignancy
• Adult: IV INFUSION 4 mg, given as single infusion over ≥15 min; may re-treat with 4 mg if serum calcium does not return to normal within 1 wk Multiple myeloma/metastatic bone lesions
Candidate age grouping · source page 1399
Hypercalcemia of malignancy
• Adult: IV INFUSION 4 mg, give over 15 min q3-4wk Osteoporosis
Candidate age grouping · source page 1399
Hypercalcemia of malignancy
• Adult: IV INFUSION 5 mg over ≥15 min q12mo Active Paget’s disease (Reclast)
Candidate age grouping · source page 1399
Hypercalcemia of malignancy
• Adult: IV INFUSION 5 mg over ≥15 min with 1500 mg elemental calcium in divided doses and 800 IU of vitamin D Osteoporosis prophylaxis (Reclast), postmenopausal women
Candidate age grouping · source page 1399
Hypercalcemia of malignancy
• Adult: IV INFUSION 5 mg every other year Osteoporosis prophylaxis (Reclast) when taking systemic glucocorticoids
Candidate age grouping · source page 1399
Hypercalcemia of malignancy
• Adult: IV 5 mg every year Renal dose
Candidate age grouping · source page 1399
Hypercalcemia of malignancy
• Adult: IV INFUSION CCr 50-60 mL/min, 3.5 mg; CCr 40-49 mL/min, 3.3 mg; CCr 30- 39 mL/min, 3 mg; CCr <30 mL/min, do not use Osteopenia prevention in androgen deprivation treatment (prostate cancer) (unlabeled)
Candidate age grouping · source page 1399
Hypercalcemia of malignancy
• Adult: IV 4 mg q6-12mo or 5 mg q12mo
Candidate age grouping · source page 1399